| Characteristic | Ethnicity; no. (%) of patients | p value | ||
|---|---|---|---|---|
| Chinese n = 2884 | Other Canadians n = 103 940 | South Asian n = 1875 | ||
| Age, yr | ||||
| 65-74 | 967 (33.5) | 30 490 (29.3) | 815 (43.5) | < 0.001 |
| 75-84 | 1328 (46.0) | 48 468 (46.6) | 775 (41.3) | |
| ≥ 85 | 589 (20.4) | 24 982 (24.0) | 285 (15.2) | |
| Women | 1592 (55.2) | 56 072 (53.9) | 943 (50.3) | 0.003 |
| Live in British Columbia | 1050 (36.4) | 18 677 (18.0) | 716 (38.2) | < 0.001 |
| Median neighbourhood income quintile* | ||||
| Q1 (lowest) | 793 (27.5) | 23 755 (22.8) | 530 (28.3) | < 0.001 |
| Q2 | 677 (23.5) | 22 435 (21.6) | 460 (24.5) | |
| Q3 | 515 (17.8) | 20 084 (19.3) | 406 (21.6) | |
| Q4 | 489 (17.0) | 18 390 (17.7) | 261 (13.9) | |
| Q5 (highest) | 386 (13.4) | 18 419 (17.7) | 208 (11.1) | |
| Hypertension | 675 (23.4) | 20 598 (19.8) | 477 (25.4) | < 0.001 |
| Diabetes | 337 (11.7) | 8661 (8.3) | 301 (16.0) | < 0.001 |
| Acute myocardial infarction | 76 (2.6) | 4768 (4.6) | 75 (4.0) | < 0.001 |
| Heart failure | 100 (3.5) | 5073 (4.9) | 101 (5.4) | 0.001 |
| Atrial fibrillation | 363 (12.6) | 12 368 (11.9) | 151 (8.0) | < 0.001 |
| Admitting physician | ||||
| Family physician | 851 (29.5) | 55 441 (53.3) | 761 (40.6) | < 0.001 |
| Internist | 1291 (44.8) | 24 795 (23.8) | 627 (33.4) | |
| Neurologist | 455 (15.8) | 14 074 (13.5) | 322 (17.2) | |
| Other | 287 (10.0) | 9630 (9.3) | 165 (8.8) | |
| Medication(s) prescribed in 6 mo before stroke | ||||
| ACE inhibitor | 762 (26.4) | 37 309 (35.9) | 687 (36.6) | < 0.001 |
| β-blocker | 840 (29.1) | 31 066 (29.9) | 548 (29.2) | 0.6 |
| Angiotensin-receptor blocker | 451 (15.6) | 8662 (8.3) | 215 (11.5) | < 0.001 |
| Calcium-channel blocker | 864 (30.0) | 28 407 (27.3) | 558 (29.8) | 0.006 |
| Diuretic | 593 (20.6) | 32 328 (31.1) | 504 (26.9) | < 0.001 |
| Any antihypertensive | 1970 (68.3) | 72 111 (69.4) | 1301 (69.4) | 0.5 |
| Acetylsalicylic acid | 411 (14.2) | 14 561 (14.0) | 310 (16.5) | 0.007 |
| Statin | 631 (21.9) | 24 720 (23.8) | 557 (29.7) | < 0.001 |
| Warfarin† | 71 (19.6) | 3410 (27.6) | 37 (24.5) | 0.002 |
Note: ACE = angioten-converting-enzyme.
*Missing for 0.8% of patients.
†Among patients with atrial fibrillation.